A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia

被引:255
作者
Wulf, GG
Wang, RY
Kuehnle, I
Weidner, D
Marini, F
Brenner, MK
Andreeff, M
Goodell, MA
机构
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1182/blood.V98.4.1166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The hematopoietic stem cell underlying acute myeloid leukemia (AML) is controversial. Flow cytometry and the DNA-binding dye Hoechst 33342 were previously used to identify a distinct subset of murine hematopoietic stem cells, termed the side population (SP), which rapidly expels Hoechst dye and can reconstitute the bone marrow of lethally irradiated mice. Here, the prevalence and pathogenic role of SP cells in human AML were investigated. Such cells were found in the bone marrow of more than 80% of 61 patients and had a predominant CD34(low/-) immunophenotype. importantly, they carried cytogenetic markers of AML in all 11 cases of active disease examined and in 2 out of 5 cases in complete hematological remission. Comparison of daunorubicin and mitoxantrone fluorescence emission profiles revealed significantly higher drug eff lux from leukemic SP cells than from non-SP cells. Three of 28 SP cell transplants generated overt AML-like disease in nonobese diabetic-severe combined immunodeficient mice. Low but persistent numbers of leukemic SP cells were detected by molecular and immunological assays in half of the remaining mice. Taken together, these findings indicate that SP cells are frequently involved in human AML and may be a target for leukemic transformation. They also suggest a mechanism by which SP cells could escape the effects of cytostatic drugs and might eventually contribute to leukemia relapse.
引用
收藏
页码:1166 / 1173
页数:8
相关论文
共 28 条
[1]   Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice [J].
Ailles, LE ;
Gerhard, B ;
Kawagoe, M ;
Hogge, DE .
BLOOD, 1999, 94 (05) :1761-1772
[2]  
BEELER TJ, 1993, J MEMBRANE BIOL, V135, P109
[3]   ANTIGEN CD34+ MARROW-CELLS ENGRAFT LETHALLY IRRADIATED BABOONS [J].
BERENSON, RJ ;
ANDREWS, RG ;
BENSINGER, WI ;
KALAMASZ, D ;
KNITTER, G ;
BUCKNER, CD ;
BERNSTEIN, ID .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (03) :951-955
[4]   Multilineage long-term engraftment potential of drug-resistant hematopoietic progenitors [J].
Bertolini, F ;
Battaglia, M ;
Lanza, A ;
Gibelli, N ;
Palermo, B ;
Pavesi, L ;
Caprotti, M ;
dellaCuna, GR .
BLOOD, 1997, 90 (08) :3027-3036
[5]   A newly discovered class of human hematopoietic cells with SCID-repopulating activity [J].
Bhatia, M ;
Bonnet, D ;
Murdoch, B ;
Gan, OI ;
Dick, JE .
NATURE MEDICINE, 1998, 4 (09) :1038-1045
[6]   Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo [J].
Blair, A ;
Hogge, DE ;
Ailles, LE ;
Lansdorp, PM ;
Sutherland, HJ .
BLOOD, 1997, 89 (09) :3104-3112
[7]   Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34+/CD71-/HLA-DR- [J].
Blair, A ;
Hogge, DE ;
Sutherland, HJ .
BLOOD, 1998, 92 (11) :4325-4335
[8]   Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].
Bonnet, D ;
Dick, JE .
NATURE MEDICINE, 1997, 3 (07) :730-737
[9]  
Bradford GB, 1997, EXP HEMATOL, V25, P445
[10]   Purification and expansion of human hematopoietic stem progenitor cells [J].
Civin, CI ;
Small, D .
BONE MARROW TRANSPLANTATION: FOUNDATIONS FOR THE 21ST CENTURY, 1995, 770 :91-98